Nantong Jinghua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FLUOROURACIL USP, with a corresponding US DMF Number 18478.
Remarkably, this DMF maintains an Active status since its submission on June 28, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 06, 2020, and payment made on April 29, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II